Holen Sie sich die Stockscreener-App
0.4705
7.20%
-0.0365
Handel nachbörslich:
.47
-0.0005
-0.11%
Schlusskurs vom Vortag:
$0.507
Offen:
$0.5248
24-Stunden-Volumen:
3.86M
Relative Volume:
0.50
Marktkapitalisierung:
$4.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.07M
KGV:
-0.0814
EPS:
-5.78
Netto-Cashflow:
$-7.34M
1W Leistung:
+27.85%
1M Leistung:
+91.73%
6M Leistung:
-51.19%
1J Leistung:
-55.61%
1-Tages-Spanne:
$0.3513
$0.5248
1-Wochen-Bereich:
$0.3513
$0.5248
52-Wochen-Spanne:
$0.22
$3.00
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Firmenname
Adial Pharmaceuticals Inc
Sektor
Branche
Telefon
434-422-9800
Adresse
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Vergleichen Sie ADIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.4705 | 5.81M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2018-10-30 | Eingeleitet | Maxim Group | Buy |
| 2018-10-11 | Eingeleitet | Dawson James | Buy |
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
Adial Pharmaceuticals Inc. Stock Analysis and ForecastFree Stock Market Beginners Guide - jammulinksnews.com
Is Adial Pharmaceuticals Inc. a good long term investmentFree Stock Market Real-Time Monitoring - jammulinksnews.com
What analysts say about Adial Pharmaceuticals Inc. stockUnrivaled growth potential - Autocar Professional
What drives Adial Pharmaceuticals Inc. stock priceSky-high return potential - jammulinksnews.com
Autolus Therapeutics Soars 10.79% on EU Approval of AUCATZYL - AInvest
Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - MSN
Adial Pharmaceuticals Regains Nasdaq Compliance After Offering - TipRanks
Adial Pharmaceuticals (ADIL) Regains Nasdaq Compliance | ADIL St - GuruFocus
Adial Pharmaceuticals regains Nasdaq compliance after equity offering By Investing.com - Investing.com Nigeria
Adial Pharmaceuticals regains Nasdaq compliance after equity offering - Investing.com
Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement - GlobeNewswire
Adial Pharmaceuticals Secures Future on Nasdaq: Key $2.5M Equity Requirement Achieved - Stock Titan
How Adial Pharmaceuticals Inc. stock performs during market volatilityReal Time Breakout Tracking - Newser
What makes Adial Pharmaceuticals Inc. stock price move sharplyBreakout Level Watch - Newser
Why Adial Pharmaceuticals Inc. stock attracts strong analyst attentionDaily Swing Candidates - Newser
Adial Pharmaceuticals Raises $3.6 Million to Meet Nasdaq Rules - MSN
Adial Pharmaceuticals Inc. Plunges 14.63% Amid Market Volatility - AInvest
Local Bounti (LOCL) insider files Form 144 to sell 3,500 shares - Stock Titan
Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Adial Pharmaceuticals Files PCT Patent Application to - GlobeNewswire
Adial Pharmaceuticals files patent update for alcohol disorder treatment By Investing.com - Investing.com Canada
Adial Pharmaceuticals, Inc. Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to At Least 2045 - MarketScreener
Adial Pharmaceuticals Files Update to Provisional Patent Application for AD04, Enhancing Intellectual Property Protection through 2045 - Quiver Quantitative
Adial Pharmaceuticals files patent update for alcohol disorder treatment - Investing.com
Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck - Yahoo Finance
Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):